Brian Chen, PhD, JD


Precision Medicine and Sharing Medical Data in Real Time: Opportunities and Barriers

Facilitating real-time data sharing while protecting individual privacy, reducing the risk of data misuse, and enhancing public trust becomes critical as precision medicine moves forward.

Kevin H. Nguyen, MS


Overuse and Insurance Plan Type in a Privately Insured Population

Health insurance plan type may be an important lever for reducing low-value healthcare use among patients with commercial insurance.

D. Priyantha Devapriya, PhD


Factors Associated With Timeliness in Academic General Surgery Clinics: A Prospective Quality Assessment

The participation of residents and physician assistants significantly increased patient wait time without reducing the attending surgeon’s consultation length in outpatient surgery clinics.

José Bernabéu Wittel, MD


“Lean” Improvement in the Quality of Patient Care in the Hospital Admissions Process

The objective of this work is to improve the quality of patient care in the admission office service of the University Hospital Virgen del Rocío (HUVR) by standardizing and systematizing its procedures using Lean methodology. The results have allowed HUVR to achieve continuous improvement in the process, eliminating the elements that do not add value.

Shahrzad Bazargan-Hejazi, PhD


The Impact of Patient Assistance Programs and the 340B Drug Pricing Program on Medication Cost

Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.

B. Guy D'Andrea, MBA


Physicians Respond to Pay-for-Performance Incentives: Larger Incentives Yield Greater Participation

Physician participation rates in a pay-for-performance program are related to the amount of rewards offered.

Tim Peoples, MA


Resource Utilization With Insulin Pump Therapy for Type 2 Diabetes Mellitus

A retrospective claims analysis of managed care enrollees with type 2 diabetes mellitus showed that insulin pump therapy reduced antidiabetic drug and healthcare resource use.

Richard Grieve, PhD


One Size Does Not Always Fit All in Value Assessment

Laying a clear path for incorporating reliable evidence on heterogeneity in value assessments could improve their applicability for healthcare decision making.

Michael Anne Kyle, MSN, MPH


Spending Variation Among ACOs in the Medicare Shared Savings Program

Analysis of spending differences among accountable care organizations (ACOs) may help identify cost savings opportunities. We examined the magnitude and sources of spending variation among ACOs over 4 years.

Zachary A. Marcum, PharmD, PhD


Impact of a Value-Based Formulary in Three Chronic Disease Cohorts

A value-based formulary was implemented that used cost-effectiveness analysis to inform medication co-payments. Diabetes cohort expenditures decreased by $9 per member per month.

Stephen Shortell, PhD


Bending the Curve Through Health Reform Implementation

Authors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.

Jeffery M. Peppercorn, MD, MPH


The Utility of Cost Discussions Between Patients With Cancer and Oncologists

Many patients with cancer desire cost discussions with doctors, but those discussions are rare. Nevertheless, cost discussions may lower patient costs-usually without altering treatment.

Katherine A. Auger, MD, MSc


Measures of ED Utilization in a National Cohort of Children

Through analysis of multistate Medicaid data, this study identifies differences in 2 commonly used measures of emergency department (ED) utilization, ED visit count and ED reliance.

Scott Hasler, MD


Patient Safety Intervention to Reduce Unnecessary Red Blood Cell Utilization

This study evaluated the impact of a patient safety intervention and national guideline to reduce unnecessary red blood cell transfusions in a large, urban academic medical center.

Terence K. Shea, PharmD


Distal Upper and Lower Limb Fractures Associated With Thiazolidinedione Use

This study demonstrates that patients with diabetes taking thiazolidinediones have higher proportions of distal upper and lower limb fractures than those not taking the drug.

Andrea D. Gelzer, MD


Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With Polypharmacy

Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.

Heidi C. Waters, PhD, MBA


A Claims-Based Algorithm to Reduce Relapse and Cost in Schizophrenia

Implementing a claims-based algorithm and disease management program may be an effective strategy to reduce relapse and cost among patients with schizophrenia.

Ronald A. Cantrell, PhD


Pragmatic Clinical Trials: US Payers' Views on Their Value

Payers like key traits of pragmatic clinical trials, but are wary of pharmaceutical companies and plan to carefully scrutinize this new, appealing type of evidence.

© 2023 MJH Life Sciences
All rights reserved.